Met Life Investment Management, LLC Cyma Bay Therapeutics, Inc. Transaction History

Met Life Investment Management, LLC

  • $16.6 Billion
  • Q2 2024

Shares

44 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$12.63 - $24.47 $96,493 - $186,950
7,640 Added 14.75%
59,442 $1.4 Million
Q3 2023

May 09, 2024
BUY
$10.86 - $17.62 $562,569 - $912,751
51,802 New
51,802 $772,000
Q2 2023

Apr 29, 2024
BUY
$7.47 - $10.95 $386,960 - $567,231
51,802 New
51,802 $567,000
Q2 2023

Aug 10, 2023
BUY
$7.47 - $10.95 $386,960 - $567,231
51,802 New
51,802 $567,000
Q2 2022

Aug 11, 2022
SELL
$1.72 - $3.39 $90,021 - $177,425
-52,338 Closed
0 $0
Q1 2022

May 10, 2024
BUY
$2.77 - $3.64 $144,976 - $190,510
52,338 New
52,338 $162,000
Q1 2022

Jun 20, 2023
BUY
$2.77 - $3.64 $144,976 - $190,510
52,338 New
52,338 $162,000
Q1 2022

Mar 22, 2023
BUY
$2.77 - $3.64 $71,601 - $94,090
25,849 Added 97.58%
52,338 $162,000
Q1 2022

May 12, 2022
BUY
$2.77 - $3.64 $144,976 - $190,510
52,338 New
52,338 $163,000
Q4 2021

Feb 15, 2022
SELL
$3.23 - $4.6 $85,559 - $121,849
-26,489 Closed
0 $0
Q3 2021

May 17, 2024
SELL
$3.47 - $4.42 $16,527 - $21,052
-4,763 Reduced 15.24%
26,489 $96,000
Q3 2021

Jun 21, 2023
BUY
$3.47 - $4.42 $91,916 - $117,081
26,489 New
26,489 $96,000
Q3 2021

Mar 22, 2023
SELL
$3.47 - $4.42 $16,527 - $21,052
-4,763 Reduced 15.24%
26,489 $96,000
Q3 2021

Nov 15, 2021
BUY
$3.47 - $4.42 $91,916 - $117,081
26,489 New
26,489 $97,000
Q2 2021

Aug 16, 2021
SELL
$3.94 - $4.92 $123,132 - $153,759
-31,252 Closed
0 $0
Q1 2021

May 17, 2024
BUY
$4.23 - $6.55 $132,195 - $204,700
31,252 New
31,252 $141,000
Q1 2021

Jun 26, 2023
BUY
$4.23 - $6.55 $132,195 - $204,700
31,252 New
31,252 $142 Million
Q1 2021

Mar 22, 2023
BUY
$4.23 - $6.55 $67,506 - $104,531
15,959 Added 104.35%
31,252 $141,000
Q1 2021

May 14, 2021
BUY
$4.23 - $6.55 $67,506 - $104,531
15,959 Added 104.35%
31,252 $142,000
Q4 2020

May 24, 2024
SELL
$5.73 - $9.03 $35,016 - $55,182
-6,111 Reduced 28.55%
15,293 $87,000
Q4 2020

Jun 22, 2023
BUY
$5.73 - $9.03 $87,628 - $138,095
15,293 New
15,293 $87,000
Q4 2020

Mar 22, 2023
SELL
$5.73 - $9.03 $35,016 - $55,182
-6,111 Reduced 28.55%
15,293 $87,000
Q4 2020

Feb 16, 2021
SELL
$5.73 - $9.03 $35,016 - $55,182
-6,111 Reduced 28.55%
15,293 $88,000
Q3 2020

May 24, 2024
SELL
$3.32 - $7.24 $44,677 - $97,428
-13,457 Reduced 38.6%
21,404 $155 Million
Q3 2020

Jun 26, 2023
BUY
$3.32 - $7.24 $71,061 - $154,964
21,404 New
21,404 $154,000
Q3 2020

Mar 22, 2023
SELL
$3.32 - $7.24 $44,677 - $97,428
-13,457 Reduced 38.6%
21,404 $154,000
Q3 2020

Nov 13, 2020
SELL
$3.32 - $7.24 $44,677 - $97,428
-13,457 Reduced 38.6%
21,404 $155,000
Q2 2020

May 24, 2024
BUY
$1.41 - $4.25 $49,154 - $148,159
34,861 New
34,861 $122 Million
Q2 2020

Jun 26, 2023
BUY
$1.41 - $4.25 $49,154 - $148,159
34,861 New
34,861 $121,000
Q2 2020

Mar 22, 2023
BUY
$1.41 - $4.25 $13,947 - $42,041
9,892 Added 39.62%
34,861 $121,000
Q2 2020

Aug 14, 2020
BUY
$1.41 - $4.25 $49,154 - $148,159
34,861 New
34,861 $122,000
Q4 2019

Feb 14, 2020
SELL
$1.33 - $5.93 $33,208 - $148,066
-24,969 Closed
0 $0
Q3 2019

Jul 12, 2023
BUY
$5.12 - $7.21 $127,841 - $180,026
24,969 New
24,969 $127,000
Q3 2019

Mar 22, 2023
SELL
$5.12 - $7.21 $16,430 - $23,136
-3,209 Reduced 11.39%
24,969 $127,000
Q3 2019

Nov 14, 2019
SELL
$5.12 - $7.21 $16,430 - $23,136
-3,209 Reduced 11.39%
24,969 $128,000
Q2 2019

Jul 12, 2023
BUY
$6.05 - $13.66 $253,192 - $571,671
41,850 New
41,850 $299,000
Q1 2019

Jul 13, 2023
BUY
$8.16 - $13.42 $229,932 - $378,148
28,178 New
28,178 $374,000
Q4 2018

Jul 13, 2023
BUY
$6.54 - $11.74 $184,284 - $330,809
28,178 New
28,178 $221,000
Q4 2018

Mar 22, 2023
SELL
$6.54 - $11.74 $101,644 - $182,463
-15,542 Reduced 35.55%
28,178 $221,000
Q4 2018

Feb 14, 2019
SELL
$6.54 - $11.74 $101,644 - $182,463
-15,542 Reduced 35.55%
28,178 $222,000
Q3 2018

Jul 13, 2023
BUY
$10.88 - $14.52 $306,576 - $409,144
28,178 New
28,178 $312,000
Q3 2018

Mar 22, 2023
BUY
$10.88 - $14.52 $475,673 - $634,814
43,720 New
43,720 $484,000
Q3 2018

Nov 14, 2018
BUY
$10.88 - $14.52 $169,096 - $225,669
15,542 Added 55.16%
43,720 $484,000
Q2 2018

Aug 15, 2018
BUY
$10.66 - $14.38 $300,377 - $405,199
28,178 New
28,178 $378,000

Others Institutions Holding CBAY

# of Institutions
7
Shares Held
1.82M
Call Options Held
0
Put Options Held
0
View Full List

About CymaBay Therapeutics, Inc.

CBAY Quotes by TradingView
  • Ticker CBAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,677,904
  • Description
  • CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...
More about CBAY
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email